Mechanistically, IGF2BP3 activates Notch3 signaling by maintaining NOTCH3 mRNA stability in an m6A-dependent manner, thus enhancing the tumor-initiating ability of DTCs and promoting the development of metastasis. Here, IGF2BP3 is linked to neoplasm.